The solvent stability of bromovirus allows for delivery of hydrophobic chemotherapeutic drugs

Abstract

Breast cancer is one of the main causes of mortality in women, and chemotherapy remains a fundamental pillar in its treatment. Although chemotherapy remains a mainstay in the treatment of breast cancer, the hydrophobicity and instability of drugs such as camptothecin (CPT) hinder their administration and bioavailability in aqueous media. To improve their solubility and stability, it is necessary to use suitable solvents that allow their encapsulation in nanovehicles without compromising their functionality. In this study, the use of viral nanoparticles (VNPs) derived from brome mosaic virus (BMV) and cowpea chlorotic mottle virus (CCMV) as platforms for the controlled delivery of CPT was investigated, evaluating the stability of the bromovirus in different polar solvents (methanol, ethanol, isopropanol, and DMSO). It was found that the viruses remain stable up to a concentration of 50% in all solvents, for at least one week except in ethanol and isopropanol, where stability is maintained up to 30%. DMSO proved to be the optimal solvent, as it preserved their size and, in addition, favored trapping CPT in VNPs. Drug entrapment was more efficient in BMV, with a 30% higher uptake compared to CCMV when DMSO-PBS was used. In silico analysis using Autodock Vina revealed that drug retention occurs through hydrophobic interactions and hydrogen bonds between viral CP and camptothecin. The computationally predicted amount of drug entrapped in virions agrees with experimental results. In vitro studies in MDA-MB-231 cells confirmed the internalization of this bromovirus VNPs in the cell nucleus and a 50% higher cytotoxicity compared to free CPT. These findings highlight the potential of plant VNPs as an innovative platform for the enhanced delivery of hydrophobic drugs in the treatment of tiple negative breast cancer.

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
21 Mar 2025
Accepted
15 Sep 2025
First published
22 Sep 2025
This article is Open Access
Creative Commons BY-NC license

Mater. Adv., 2025, Accepted Manuscript

The solvent stability of bromovirus allows for delivery of hydrophobic chemotherapeutic drugs

E. Loredo-García, M. M. Herrera-Hernandez, C. Medrano-Villagómez, P. Fournier, A. G. Rodríguez-Hernández, M. Loredo-Tovías, J. Ruiz-Garcia, B. Dragnea and R. D. Cadena-Nava, Mater. Adv., 2025, Accepted Manuscript , DOI: 10.1039/D5MA00261C

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements